VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LIMNLiminatus Pharma, Inc. Class A Common Stock
$0.11$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLIMNPrice History

LIMN logoLiminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Price History

Historical prices from 2025 to 2026

$0.11+0.01  (+9.99%)close Jun 26
Returns
1M
-35.5%
3M
-45.8%
YTD
-83.5%
1Y
-99.4%
3Y
-72.4%
5Y
-53.8%
ATH$33.66Jun 2025-99.7%
ATL$0.10Jun 2026pre-split
Avg Vol (50D)8.8M/ day
52-Week Range$0.10 — $12.90
LowCurrent: $0.11High

Loading 10-year price history...

LIMN Historical Performance

1 YearTotal Return
-99.6%
Price: -99.4%
3 YearsTotal Return
-97.9%
CAGR: -72.6%
Price: -97.9%
5 YearsTotal Return
-97.9%
CAGR: -54.0%
Price: -97.9%
YTD
-83.5%

LIMN Annual Returns

Year-by-year price performance · 2025–2026

Best-87.8%2025
Worst-87.8%2025
Up years0/2
2025-87.8%
2026-60.5%
2025 annual price return
-87.8%
2026 annual price return
-60.5%
LessMore
Alpha vs S&P 500
1Y-120.5%
3Y-91.4%
5Y-65.0%

Price returns only.

Download Historical Data

293 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

LIMN Stock Price Trajectory (2025–2026)

As of June 28, 2026, Liminatus Pharma, Inc. Class A Common Stock (LIMN) trades at $0.11, representing a -99.4% return over the past year. The stock has delivered a -97.9% total return over five years (-53.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $33.66 on June 25, 2025. From this peak, LIMN has corrected -99.7%, currently trading 85% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers SIGA (-40.2% 1Y), AGEN (-38.3% 1Y), and IMVT (+137.0% 1Y), LIMN has underperformed the peer group average. Compare LIMN vs SIGA →

LIMN Historical Price Data · from 2025

Rows 1–50 of 293
Date Open High Low Close Volume Change %
2026-06-260.100.110.100.110+9.99%
2026-06-250.110.110.100.10889K-6.79%
2026-06-240.110.110.100.101.14M-5.15%
2026-06-230.110.110.110.11910K-4.14%
2026-06-220.120.120.110.111.28M-4.87%
2026-06-180.120.120.120.12702K-2.30%
2026-06-170.110.120.110.121.16M+7.21%
2026-06-160.120.130.110.111.58M-8.52%
2026-06-150.120.130.120.1287K+0.40%
2026-06-120.140.140.120.121.99M-8.90%
2026-06-110.140.140.130.141.26M-1.09%
2026-06-100.130.150.130.142.73M+3.85%
2026-06-090.140.150.130.131.32M-6.10%
2026-06-080.140.140.130.142.20M-0.84%
2026-06-050.150.150.140.1481K-5.95%
2026-06-040.140.160.140.152.60M-0.33%
2026-06-030.150.170.140.158.00M-22.21%
2026-06-020.190.210.180.209.85M+8.27%
2026-06-010.170.190.170.186.76M+9.82%
2026-05-290.180.180.160.164.11M-8.89%
2026-05-280.180.180.170.183.21M0.00%
2026-05-270.160.190.160.187.92M+9.82%
2026-05-260.170.170.160.165.16M-3.25%
2026-05-220.180.180.130.1724.93M-31.14%
2026-05-210.310.360.230.25315.06M+30.99%
2026-05-200.190.190.180.19455K-1.16%
2026-05-190.190.190.180.19578K+1.55%
2026-05-180.190.190.180.191.22M+3.94%
2026-05-150.180.190.180.18714K-2.17%
2026-05-140.190.190.180.18498K-0.54%
2026-05-130.190.190.180.18596K-3.39%
2026-05-120.200.200.190.19683K-6.59%
2026-05-110.200.210.200.20572K+1.08%
2026-05-080.200.210.200.20700K+1.15%
2026-05-070.200.210.200.20448K-3.74%
2026-05-060.200.210.200.21634K+0.14%
2026-05-050.230.230.210.21101K-2.39%
2026-05-040.200.220.200.21553K+3.85%
2026-05-010.200.210.200.211.01M+0.54%
2026-04-300.200.210.200.20595K-0.15%
2026-04-290.200.210.200.20812K+0.25%
2026-04-280.200.210.200.20896K+0.69%
2026-04-270.200.210.200.20799K+2.17%
2026-04-240.200.200.190.20634K-0.75%
2026-04-230.220.220.190.201.18M-8.65%
2026-04-220.200.220.200.22619K+5.96%
2026-04-210.210.220.190.212.14M-4.09%
2026-04-200.210.230.210.221.71M-1.83%
2026-04-170.220.240.200.223.85M-4.74%
2026-04-160.180.230.180.2314.08M+23.92%
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LIMN — Frequently Asked Questions

Quick answers to the most common questions about buying LIMN stock.

How has LIMN stock performed recently?

LIMN declined -99.4% over the past year, below its 5-year annualized CAGR of -53.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is LIMN's all-time high price?

Liminatus Pharma, Inc. Class A Common Stock reached $33.66 on 2025-06-25. The 52-week high is $12.90. Current 1-year return of -99.4% places the stock further from historical peaks.

Where can I download LIMN historical price data?

This page provides LIMN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2025-2026, downloadable in CSV format.

293 data points